Overviewing The use of Human iPSC Derived Neuronal Models to Enable Preclinical Drug Discovery in Neurodegenerative diseases for Gene Therapy
Time: 12:00 pm
day: Preclinical Stream Day 1 AM
Details:
- Understanding the value of transcriptomic characterization of models
- Weighing pros and cons of 2D versus 3D neuronal cultures
- On neurophysiology endpoints: methods, reproducibility, and throughput
